logo

For the Inventor, By the Inventor

Auffargis, France

Anne-Marie Liberatore

This inventor holds 16 USPTO granted patents and 2 published patent applications and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.), Ipsen Pharma S.a.s.. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Marie Liberatore. Retrieved from https://idiyas.com/inventor/anne-marie-liberatore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 37.5

 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 85(Granted Patents)


Company Filing History:

goldMedal12 out of 119 
 
Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)
 patents
silverMedal4 out of 108 
 
Ipsen Pharma S.a.s.
 patents

Years Active: 2002-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Imidazolidine Derivatives
Heterocycles
Imidazole Derivatives
Cancer Drug
Sodium Channels
Camptothecin Analogues
Pyrido-Thieno-Diazepines
Medicaments
Pharmaceutical Compositions
Therapeutic Uses
Diazepines
16 patents (USPTO):Explore Patents
1. 8710091 - Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug (2014-04-29),
2. 8288560 - Derivatives of heterocycles with 5 members, their preparation and their use as medicaments (2012-10-16),
3. 8188133 - Imidazole derivatives, preparation and user thereof as medicine (2012-05-29),
4. 7956075 - Derivatives of heterocycles with 5 members, their preparation and their use as medicaments (2011-06-07),
5. 7534805 - Imidazole derivatives, their preparation and their use as medicaments (2009-05-19),
6. 7402602 - Imidazole derivatives modulating the sodium channels (2008-07-22),
7. 7192975 - Arylimidazole derivatives, preparation and therapeutic used thereof (2007-03-20),
8. 7157483 - Imidazole derivatives modulating the sodium channels (2007-01-02),
9. 7135478 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2006-11-14),
10. 7053102 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2006-05-30),
11. 7015213 - Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors (2006-03-21),
12. 6815546 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2004-11-09),
13. 6797715 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2004-09-28),
14. 6777408 - Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines (2004-08-17),
15. 6762301 - Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them (2004-07-13),

Title: Anne-Marie Liberatore: Innovator in Pharmaceutical Chemistry

Introduction

Anne-Marie Liberatore is a prominent inventor based in Auffargis, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 16 patents to her name, her work focuses on innovative solutions for treating serious medical conditions.

Latest Patents

Among her latest patents is the development of imidazolidine-2,4-dione derivatives, which are being explored for their potential as cancer drugs. This application highlights the antiproliferative activity of these compounds, making them particularly useful in treating diseases linked to abnormal cell proliferation. Additionally, she has patented derivatives of heterocycles with five members, including thiazole, oxazole, imidazole, isoxazole, and isoxazoline. These compounds possess advantageous pharmacological properties, allowing for their use in treating neurodegenerative disorders and pain.

Career Highlights

Anne-Marie has worked with notable companies such as Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Ipsen Pharma S.A.S. Her experience in these organizations has contributed to her expertise in pharmaceutical research and development.

Collaborations

Throughout her career, Anne-Marie has collaborated with esteemed colleagues, including Dennis Bigg and Jacques Pommier. These partnerships have further enriched her research and innovation efforts.

Conclusion

Anne-Marie Liberatore stands out as a leading inventor in the pharmaceutical industry, with a focus on developing innovative compounds for critical health issues. Her contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…